Limb Embolism and Ischaemia

244 Users are discussing this topic

PatientPlus articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.

See also: Medication after a Heart Attack (Myocardial Infarction) written for patients

See separate related article Peripheral Arterial Disease.

Acute limb ischaemia is most often due to either acute thrombotic occlusion of a previously partially occluded, thrombosed arterial segment, or to embolus from a distant site. Without surgical revascularisation, complete acute ischaemia leads to extensive tissue necrosis within six hours. The effects of sudden arterial occlusion depend on the state of collateral supply.[1]

  • The collateral supply in the leg is usually inadequate unless there has been pre-existing occlusive disease.
  • The subclavian artery has many collateral vessels so that occlusion of a major artery does not necessarily make an upper limb non-viable.

Critical limb ischaemia is a condition with chronic ischaemic at-rest pain, ulcers, or gangrene in one or both legs, attributable to objectively proven arterial occlusive disease. Critical limb ischaemia implies chronicity and should be distinguished from acute limb ischaemia.[2]

  • Embolism: for example, left atrial thrombus in patients in atrial fibrillation, mural thrombus after myocardial infarction, prosthetic and abnormal heart valves, aneurysm (aorta, femoral, or popliteal), proximal atheromatous stenosis, malignant tumour, or foreign body.
  • Thrombosis: most cases of leg ischaemia result from the presence of thrombus at sites of atherosclerotic narrowing; presentation of ischaemia may be:
    • Acute, as a result of emboli from rupture of proximal atherosclerotic plaque or thrombus.
    • Chronic, usually resulting from gradual extension of thrombus with development of collateral vessels.
  • Trauma.
  • Raynaud's syndrome.
  • Compartment syndrome: this occurs when perfusion pressure falls below tissue pressure in a closed anatomical space; causes include:
    • Orthopaedic (tibial or forearm fractures).
    • Vascular: haemorrhage, phlegmasia caerulea dolens (massive thrombosis in the major veins of the limbs, causing gross swelling that obstructs arterial flow).
    • Soft tissue injury (prolonged limb compression, crush injury, burns).
  • Congenital causes of early-onset leg ischaemia - eg, aortic hypoplasia.
  • Ischaemia of the arm is most often embolism of cardiac origin, but may also be due to damage to the subclavian artery or thoracic outlet syndrome.

NEW - log your activity

  • Notes
    Add notes to any clinical page and create a reflective diary
  • Track
    Automatically track and log every page you have viewed
  • Print
    Print and export a summary to use in your appraisal
Click to find out more »
  • History and examination should identify the severity of ischaemia and whether it is likely to be embolic or thrombotic.
  • Important features to differentiate include rapidity of onset of symptoms, features of pre-existing chronic arterial disease, potential source of embolus and the state of pulses in the contralateral limb.
  • The affected part becomes pale, pulseless, painful, paralysed, paraesthetic and 'perishing with cold' ('the 6 Ps').[1]
  • The onset of fixed mottling of the skin implies irreversible changes.
  • The limb may be red when dependent, leading to a misdiagnosis of inflammation - eg, gout or cellulitis.
  • Hand-held Doppler ultrasound scan may help demonstrate any residual arterial flow.
  • Blood tests
    • FBC (ischaemia is aggravated by anaemia).
    • ESR (inflammatory disease - eg, giant cell arteritis, other connective tissue disorders).
    • Glucose (diabetes).
    • Lipids.
    • Thrombophilia screen.
  • If diagnosis is in doubt, perform urgent arteriography.
  • Investigations to identify the source of embolus:
    • ECG.
    • Echocardiogram.
    • Aortic ultrasound.
    • Popliteal and femoral artery ultrasound.
  • Urgent admission - this is an emergency and often requires urgent open surgery or angioplasty. Objective sensory loss requires urgent treatment. Heparinisation is needed immediately (this may double the limb salvage rate), and provide analgesia.
  • Ischaemia following trauma and acute thrombosis may require urgent reconstruction.
  • The limb must be checked for evidence of compartment syndrome and, if necessary, a fasciotomy should be performed.
  • If the occlusion is embolic, the options are surgical embolectomy (Fogarty balloon embolectomy catheter) or local intra-arterial thrombolysis:
    • If embolectomy with a Fogarty catheter fails, an on-table angiogram is performed and bypass graft or intraoperative thrombolysis considered. Routine intraoperative angiography for arterial thromboembolectomy has been shown to be beneficial.[3]
    • After successful embolectomy, anticoagulation with heparin is needed to prevent recurrence. Many surgeons postpone heparin for six hours after surgery to reduce the risk of a haematoma.[4]
  • If the occlusion is due to thrombotic disease the options are intra-arterial thrombolysis, angioplasty or bypass surgery. If due to thrombosis of an arterial graft, then thrombolysis is the first step.
  • Intra-arterial thrombolysis:[5]
    • For patients with acute arterial emboli or thrombosis, treatment with immediate systemic anticoagulation with unfractionated heparin has been recommended. This should be followed by long-term warfarin in patients with embolism.[6]
    • An arteriogram is performed and the catheter advanced into the thrombus. Streptokinase, urokinase or tissue plasminogen activator (tPA) should be combined with heparin and thrombolysis continued for 48 hours or until clot lysis.[1]
    • Fibrinolysis usually takes between 6 and 72 hours to achieve clot lysis and so patients with limb-threatening ischaemia are not candidates for local fibrinolysis, and require emergent embolectomy.
    • Local thrombolytic therapy is therefore reserved for patients with non-life-threatening limb ischaemia.
    • Thrombolysis can be accelerated by using pulse spray through a multiple side-hole catheter, aspiration thrombectomy (debulking thrombus aspiration) and by using a high dose over a shorter time.
    • Complications of thrombolysis are haemorrhage, pericatheter thrombosis, haemorrhagic stroke and distal embolisation.
    • The contra-indications are critical ischaemia with neurological deficit, and irreversible ischaemic changes.
    • Recombinant tissue plasminogen activator (the preferred agent): up to 60-90% of thromboses will show clinically useful lysis. However, there is a high rate of reocclusion.[1]
    • Following successful lysis, correction of the underlying problem, possibly including angioplasty or operation, may be required.
  • If a limb is irreversibly ischaemic, amputation will be required.

Other management

  • Reduction in the rate of deterioration of underlying cardiovascular disease includes regular exercise, smoking cessation, treating hypertension and hyperlipidaemia, and improving diabetes control.
  • Management of associated and underlying problems: treat anaemia or polycythaemia, cardiac disease.
  • Low-dose aspirin or clopidogrel. Warfarin if otherwise indicated.
  • Angiotensin-converting enzyme (ACE) inhibitors have been shown to reduce morbidity and mortality due to cardiovascular disease in patients with peripheral arterial disease by 25%.
  • Statins to reduce total and low-density lipoprotein (LDL) cholesterol.
  • Reperfusion injury may cause more damage than the initial ischaemia:
    • Neutrophils migrate into the reperfused tissue, causing injury.
    • Limb swelling due to increased capillary permeability may cause a compartment syndrome.
    • Leakage from damaged cells may cause acidosis and hyperkalaemia (leading to cardiac arrhythmias) and myoglobinaemia (leading to acute tubular necrosis).
  • Chronic pain syndromes: acute complete ischaemia can lead to peripheral nerve injury.
  • Complete acute ischaemia will lead to extensive tissue necrosis within six hours unless the limb is surgically revascularised.[4]
  • The mortality associated with acute ischaemia remains high, as thrombosis or embolism is not infrequently a pre-terminal event in patients dying from other causes, such as heart failure.
  • A Cochrane review of surgery versus thrombolysis found no overall difference in limb salvage or death at one year between initial surgery and initial thrombolysis. Thrombolysis may be associated with a higher risk of ongoing limb ischaemia and haemorrhagic complications including stroke. The higher risk of complications must be balanced against risks of surgery in each person.[7] 
  • Surgical treatment of acute limb ischaemia has a 30-day mortality rate of 15-25%, mainly because of related complications.[8]
  • Long-term anticoagulation for potential causes of thromboembolism.
  • Primary prevention of cardiovascular disease; secondary prevention of cardiovascular disease.

Further reading & references

  1. Acute limb ischaemia; Surgical Tutor
  2. Ballard JL, Mills JL Sr; Surgical management of critical limb ischemia. Tech Vasc Interv Radiol. 2005 Dec;8(4):169-74.
  3. Ebner H, Zaraca F, Randone B; The role of intraoperative angiography in arterial thromboembolectomy for non-traumatic acute upper limb ischaemia. Chir Ital. 2004 May-Jun;56(3):345-50.
  4. Callum K, Bradbury A; ABC of arterial and venous disease: Acute limb ischaemia. BMJ. 2000 Mar 18;320(7237):764-7.
  5. Kessel DO, Berridge DC, Robertson I; Infusion techniques for peripheral arterial thrombolysis. Cochrane Database Syst Rev. 2004;(1):CD000985.
  6. Clagett GP, Sobel M, Jackson MR, et al; Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep;126(3 Suppl):609S-626S.
  7. Berridge DC, Kessel DO, Robertson I; Surgery versus thrombolysis for initial management of acute limb ischaemia. Cochrane Database Syst Rev. 2013 Jun 6;6:CD002784. doi: 10.1002/14651858.CD002784.pub2.
  8. Giannini D, Balbarini A; Thrombolytic therapy in peripheral arterial disease. Curr Drug Targets Cardiovasc Haematol Disord. 2004 Sep;4(3):249-58.

Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.

Original Author:
Dr Colin Tidy
Current Version:
Peer Reviewer:
Dr Hannah Gronow
Document ID:
2387 (v22)
Last Checked:
22/07/2014
Next Review:
21/07/2019

Did you find this health information useful?

Yes No

Thank you for your feedback!

Subcribe to the Patient newsletter for healthcare and news updates.

We would love to hear your feedback!

 
 
Patient Access app - find out more Patient facebook page - Like our page